Skip to content

Mechanistic Study of the "One-Origin Three-Branch" Circular Movement Acupuncture Theory in Improving Ovarian Function in Patients with Premature Ovarian Insufficiency Based on Multi-Omics Technologies

Clinical Study of the Circular Motion Acupuncture Method Based on the "One Source, Three Branches" Theory for Premature Ovarian Insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001739
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Insufficiency

Interventions

POI Acupuncture Group:IVF-ET following treatment with the Circular Motion Acupuncture Method based on the "One Source, Three Branches" Theory
POI Non-acupuncture Group:Routine IVF-ET Treatment
Non-female-factor Control Group:Routine IVF-ET Treatment

Sponsors

Hubei Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1)Women scheduled to undergo in vitro fertilization and embryo transfer (IVF-ET) procedures and routine oocyte retrieval; (2)Residual follicular fluid samples that would otherwise be discarded after routine clinical processing can be obtained during oocyte retrieval; (3)Participants in the POI intervention group and POI control group meet the diagnostic criteria for Premature Ovarian Insufficiency (POI) or are assessed by reproductive specialists as having diminished ovarian function; (4)Participants in the non-ovarian-factor control group undergo assisted reproductive treatment due to non-ovarian factors, such as male-factor infertility or tubal-factor infertility. Female participants have normal ovarian reserve function and no confirmed POI or other reproductive endocrine disorders that may significantly affect follicular fluid test results; (5)Able to understand the study procedures, voluntarily participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: (1) Participants with severe diseases involving major organs or systems, including the cardiovascular, hepatic, renal, or hematopoietic systems; (2) Participants with malignant tumors, severe infections, or other diseases that, in the opinion of the investigators, may significantly affect the results of follicular fluid analysis; (3) Participants whose follicular fluid samples are obviously blood-stained, contaminated, or insufficient in volume to meet the testing requirements; (4) Participants with incomplete clinical data or those considered unsuitable for inclusion by the investigators.

Design outcomes

Primary

MeasureTime frame
Transcriptomic Characteristics of Follicular Fluid;

Secondary

MeasureTime frame
Differentially Expressed Genes;Differential Metabolites;Differentially Expressed Proteins;

Countries

China

Contacts

Public ContactGuo jianfang

Hubei Maternity and Child Health Care Hospital

1416575583@qq.com13986323854

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026